You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬泰生物(603392.SH):結核感染 T 細胞檢測試劑盒(體外釋放酶聯免疫法)被納入聯合國項目事務署採購清單
格隆匯 04-09 16:09

格隆匯4月9日丨萬泰生物(603392.SH)公佈,公司自主研發的結核感染 T 細胞檢測試劑盒(體外釋放酶聯免疫法)(簡稱“TB-IGRA檢測試劑盒”)被納入聯合國項目事務署(UNOPS)管理的StopTB Partnership 採購清單。

UNOPS 作爲聯合國系統內重要的採購機構,其採購清單的納入意味着公司的 TB-IGRA 檢測試劑盒獲得了國際權威認可,可直接參與聯合國及全球多邊機構的集中採購項目,覆蓋更多發展中國家和地區,將對公司開拓國際市場帶來積極影響,有利於進一步提升公司產品的國際競爭力。結核病是全球公共衛生問題,UNOPS 等機構在醫療物資採購中尤其關注結核病篩查和防治產品,公司TB-IGRA 檢測試劑盒通過 UNOPS 進入此類採購鏈,有助於滿足全球中低收入國家對結核病檢測的需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account